Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Depsipeptides × 1 year × Clear all

Sponsor

Conditions

Lymphoma, T-Cell, Cutaneous 3 Mycosis Fungoides 2 Breast Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Prolymphocytic, T-Cell 1 Inflammatory Breast Neoplasms 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Breast Neoplasms, Male 1

Interventions

pembrolizumab 71 Nivolumab 71 cabozantinib 46 Ipilimumab 38 Magnetic Resonance Spectroscopy 32 Specimen Handling 31 lenvatinib 24 Axitinib 24 belzutifan 18 Sunitinib 18 Biopsy 15 CTLA-4 Antigen 14 Radiosurgery 13 atezolizumab 11 Everolimus 10 Bevacizumab 9 pazopanib 8 avelumab 8 Radiotherapy 8 Nephrectomy 7 Immunoglobulin G 7 Cyclophosphamide 7 toripalimab 6 fludarabine 6 cemiplimab 6 aldesleukin 6 Standard of Care 6 Paclitaxel 6 Blood Specimen Collection 6 spartalizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡